Pfizer, Wyeth Divest Some Assets to Boehringer
GLOBAL - Pfizer and Wyeth are to divest certain animal health assets to Boehringer Ingelheim. The agreement is subject to regulatory approval in several countries. The Pfizer/Wyeth transaction is expected to close early in the fourth quarter 2009.